{
  "schemaVersion": 1,
  "id": "research-195",
  "slug": "195-how-removing-different-numbers-of-residues-changed-a-cell-assay",
  "title": "How removing different numbers of residues changed a cell assay",
  "catalogLabel": "IGF-1 DES 1,3",
  "productCollection": "https://heritagebiolabs.com/research-library/products/igf-1-des-1-3",
  "productHandles": [
    "igf-1-des-1-3-440"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/igf-1-des-1-3-440"
  ],
  "readingFocus": "Methods & identity",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 261,
  "sourceYears": [
    1989
  ],
  "paragraphs": [
    "Short amino-acid chains connected by peptide bonds can carry biological signals. Cutting the chain can change how a signal behaves. IGF-1 DES 1,3 refers to des(1–3)IGF-1, a 67-residue form lacking the first three amino acids of full-length IGF-1. An older experiment tested whether the number of removed residues changed the effect on protein production in a cell model. [1]",
    "No recent primary study repeating this exact sequence comparison was identified. The investigators made IGF-1 variants shortened by one to five residues and compared them in cultured rat muscle precursor cells. They measured how much of each variant was needed to produce a defined response in a protein synthesis assay. The three-residue deletion produced a response at a lower concentration than intact IGF-1. The five-residue deletion was much less active in that assay. [1]",
    "The investigators also compared how well the variants competed for binding. They found that the shorter variants interacted differently with proteins released by the cultured cells, which can capture IGF-1 before it reaches a receptor. Further shortening could also weaken the ability to bind to the receptor itself. The sequence comparison allowed the researchers to ask separately how much of the peptide was available to act and how well it could engage the target. [1]",
    "The older results apply to defined molecules in a laboratory assay. A stronger response at a lower concentration in these rat cells is a measurement of potency under those conditions. The result does not describe human growth, muscle strength, or what would happen in a tissue with different receptor and binding-protein levels. [1]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Bagley CJ et al. A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide. Biochemical Journal (publication 1989-05-01).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/2730580/"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/195-how-removing-different-numbers-of-residues-changed-a-cell-assay",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/195-how-removing-different-numbers-of-residues-changed-a-cell-assay.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/195-how-removing-different-numbers-of-residues-changed-a-cell-assay.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 039 - IGF-1 Human and IGF-1 DES 1 3.docx",
    "sourceArticleNumber": 195,
    "contentSha256": "b4974fb2054e68883fe39093ac0eed3675357c9cd5a4e46f69ea16d177c7fd13",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
